据中外制药官网消息,8月18日,中外制药宣布已与葛兰素史克签署独家许可协议,葛兰素史克将获得抗登革热病毒抗体药物“AID351”的全球独家开发、生产和商业化权利,并负责该药物的临床开发及生产。(文章来源:第一财经)
Source Link据中外制药官网消息,8月18日,中外制药宣布已与葛兰素史克签署独家许可协议,葛兰素史克将获得抗登革热病毒抗体药物“AID351”的全球独家开发、生产和商业化权利,并负责该药物的临床开发及生产。(文章来源:第一财经)
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.